immunitybio(ibrx
ImmunityBio(IBRX):
ImmunityBio(IBRX) 8-K Current report, items 8.01 and 9.01 Accession Number: 0001326110-23-000014 Act: 34 Size: 177 KB 网页链接
ImmunityBio(IBRX):
ImmunityBio(IBRX) 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001326110-23-000018 Act: 34 Size: 21 MB 网页链接
ImmunityBio(IBRX):
ImmunityBio(IBRX) 8-K Current report, items 8.01 and 9.01 Accession Number: 0001326110-23-000023 Act: 34 Size: 198 KB 网页链接
ImmunityBio(IBRX):
ImmunityBio(IBRX) 8-K Current report, item 2.02 Accession Number: 0001193125-23-039399 Act: 34 Size: 141 KB 网页链接
ImmunityBio(IBRX):
ImmunityBio(IBRX) 3/A [Amend] Initial statement of beneficial ownership of securities Accession Number: 0001326110-23-000019 Size: 4 KB 网页链接
ImmunityBio(IBRX):
ImmunityBio(IBRX) EFFECT Notice of Effectiveness Accession Number: 9999999995-23-000358 Act: 33 Size: 1 KB 网页链接
ImmunityBio(IBRX):
ImmunityBio(IBRX) 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001193125-23-040509 Act: 33 Size: 670 KB 网页链接
ImmunityBio(IBRX):
ImmunityBio(IBRX) 8-K Current report, items 1.01, 2.03, and 9.01 Accession Number: 0001326110-23-000028 Act: 34 Size: 232 KB 网页链接
ImmunityBio(IBRX):
ImmunityBio(IBRX) S-3 Registration statement under Securities Act of 1933 Accession Number: 0001193125-23-025832 Act: 33 Size: 778 KB 网页链接





